Key Details
Annual ROE
-189.12%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 05, 2020Recent annual earnings:
Mar 12, 2020Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 06, 2020Analyst ratings
Recent major analysts updates
16 Feb '22 Ladenburg Thalmann
Buy25 Nov '20 Wells Fargo
Outperform25 Nov '20 SunTrust Robinson Humphrey
Buy25 Nov '20 Raymond James
Outperform25 Nov '20 PiperJaffray
Overweight25 Nov '20 Ladenburg Thalmann
Buy25 Nov '20 Jefferies
25 Nov '20 Guggenheim
Neutral25 Nov '20 Citigroup
Neutral25 Nov '20 Cantor Fitzgerald
BuyScreeners with BLCM included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Bellicum Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Bellicum Pharmaceuticals?
- What is the ticker symbol for Bellicum Pharmaceuticals?
- Does Bellicum Pharmaceuticals pay dividends?
- What sector is Bellicum Pharmaceuticals in?
- What industry is Bellicum Pharmaceuticals in?
- What country is Bellicum Pharmaceuticals based in?
- When did Bellicum Pharmaceuticals go public?
- Is Bellicum Pharmaceuticals in the S&P 500?
- Is Bellicum Pharmaceuticals in the NASDAQ 100?
- Is Bellicum Pharmaceuticals in the Dow Jones?
- When was Bellicum Pharmaceuticals's last earnings report?
- When does Bellicum Pharmaceuticals report earnings?
- Should I buy Bellicum Pharmaceuticals stock now?
What is the primary business of Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen. Its clinical product candidates also include BPX-603, an autologous dual-switch GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing human epidermal growth factor receptor 2 antigen. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is based in Houston, Texas.
What is the ticker symbol for Bellicum Pharmaceuticals?
The ticker symbol for Bellicum Pharmaceuticals is NASDAQ:BLCM
Does Bellicum Pharmaceuticals pay dividends?
No, Bellicum Pharmaceuticals does not pay dividends
What sector is Bellicum Pharmaceuticals in?
Bellicum Pharmaceuticals is in the Healthcare sector
What industry is Bellicum Pharmaceuticals in?
Bellicum Pharmaceuticals is in the Biotechnology industry
What country is Bellicum Pharmaceuticals based in?
Bellicum Pharmaceuticals is headquartered in United States
When did Bellicum Pharmaceuticals go public?
Bellicum Pharmaceuticals's initial public offering (IPO) was on 18 December 2014
Is Bellicum Pharmaceuticals in the S&P 500?
No, Bellicum Pharmaceuticals is not included in the S&P 500 index
Is Bellicum Pharmaceuticals in the NASDAQ 100?
No, Bellicum Pharmaceuticals is not included in the NASDAQ 100 index
Is Bellicum Pharmaceuticals in the Dow Jones?
No, Bellicum Pharmaceuticals is not included in the Dow Jones index
When was Bellicum Pharmaceuticals's last earnings report?
Bellicum Pharmaceuticals's most recent earnings report was on 5 November 2020
When does Bellicum Pharmaceuticals report earnings?
The date for Bellicum Pharmaceuticals's next earnings report has not been announced yet
Should I buy Bellicum Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions